Increasing incidence and prevalence of biochemically confirmed primary hyperparathyroidism in Stockholm, 2006-2020
CONTEXT: Primary hyperparathyroidism (PHPT) prevalence appears to be rising, but substantial underdiagnosis persist. Accurate epidemiological data are needed, requiring population-based studies using strict biochemical criteria. OBJECTIVE: To determine incidence and prevalence of biochemically confirmed PHPT in Stockholm and characterize clinical recognition and surgical management. DESIGN: Population-based healthcare cohort study using prespecified biochemical diagnostic algorithms. SETTING: Stockholm Region, Sweden, 2006-2020, using the Stockholm CREAtinine Measurements database covering two-thirds of the adult population, including ≥90% of individuals ≥65 years. PATIENTS: Adults aged ≥20 years with paired calcium and parathyroid hormone (PTH) measurements meeting biochemical criteria for PHPT. Individuals with eGFR ≤30 mL/min/1.73 m2, secondary hyperparathyroidism, or prior parathyroid surgery were excluded. MAIN OUTCOME MEASURE: Annual incidence rate and point prevalence of biochemically confirmed PHPT. RESULTS: Among 176,780 individuals contributing 578,227 PTH measurements, 10,190 patients fulfilling biochemical PHPT criteria were identified. Age- and sex-adjusted incidence rate increased from 2.81 (95% CI, 2.55-3.09) to 4.28 (95% CI, 3.98-4.59) per 10,000 person-years between 2009 and 2020, with the steepest increase among women aged ≥70 years. Prevalence increased from 0.35 to 4.76 per 1,000 individuals. Median ionized calcium was 1.39 mmol/L. Clinical diagnosis of PHPT was documented in 5,346 (52%) patients of which, 2,800 (52%) underwent parathyroidectomy, with surgery-rates stabilizing after 2013 at 4-5% annually. CONCLUSIONS: Using a large healthcare database, we observed substantially increasing PHPT incidence and prevalence, predominantly in older individuals. Only 52% received clinical diagnosis, underscoring the need for studies evaluating the long-term clinical burden of undiagnosed PHPT.
Authors
- Jan Zedenius (ORCID: https://orcid.org/0000-0003-2833-3758)
- Juan Jesús Carrero (ORCID: https://orcid.org/0000-0003-4763-2024)
- Robert Bränström (ORCID: https://orcid.org/0000-0001-6245-7223)
- David Thorsteinsson (ORCID: https://orcid.org/0009-0004-1043-1733)
- Inga‐Lena Nilsson (ORCID: https://orcid.org/0000-0002-8966-3729)
- Fredrik Granath (ORCID: https://orcid.org/0000-0001-9606-2094)
Institutions
- Karolinska University Hospital (SE)
- Danderyds sjukhus (SE)
- Karolinska Institutet (SE)
- Glanrhyd Hospital (GB)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2026-04-10
- DOI
- https://doi.org/10.1210/clinem/dgag162
- Citations
- 1
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 18.73